4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-049728
Director sold 96,136 shares at an average $35.05 ($3,369,932)
From the SEC's structured data for this filing
Trades in this filing
Schroeder Thilo · Director
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-02 | Sale : show line 1 in the form | −13,031 | $34.74 | $452,697 | 1,978,240 | I |
| 2021-08-03 | Sale : show line 2 in the form | −30,145 | $33.80 | $1,018,901 | 1,948,095 | I |
| 2021-08-03 | Sale : show line 3 in the form | −100 | $34.74 | $3,474 | 1,947,995 | I |
| 2021-08-04 | Sale : show line 4 in the form | −1,760 | $34.21 | $60,210 | 1,946,235 | I |
| 2021-08-04 | Sale : show line 5 in the form | −17,175 | $35.10 | $602,843 | 1,929,060 | I |
| 2021-08-04 | Sale : show line 6 in the form | −28,676 | $36.22 | $1,038,645 | 1,900,384 | I |
| 2021-08-04 | Sale : show line 7 in the form | −5,249 | $36.80 | $193,163 | 1,895,135 | I |
| Open-market sales · 96,136 sh · avg $35.05 · $3,369,932 | ||||||
Loading xslF345X03/doc4.xml…